Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (171-180 of 234) with videos related to

Pageof 24
Sort By:
Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Nature Communications|July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan levelShweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Pediatric Blood & Cancer|February 11, 2024
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studiesThomas Traunwieser, Elena Loos, Holger Ottensmeier, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Pageof 24

Showing results (171-180 of 234) with videos related to

Sort By:
Pageof 24
Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Nature Communications|July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan levelShweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Pediatric Blood & Cancer|February 11, 2024
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studiesThomas Traunwieser, Elena Loos, Holger Ottensmeier, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Pageof 24